Metraipolis › archive › dc_477393bebf33

Machine learning-based models for predicting the efficacy and safety of recombinant human interleukin-11 in the treatment of cancer therapy-induced… — Europe PMC PMID:42495717

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42495717
DOI: 10.3389/fcell.2026.1882398
License (as archived): solo-consultazione
Archived: 2026-10-08T10:26:12.019Z
SHA-256 of the archived text: bb0172d4af161b27a1d1a9cd1b6806960a95eed9f85cdd576a71abaec771369e
Stable URL of this page: https://metraipolis.com/documento/dc_477393bebf33

How to cite

Machine learning-based models for predicting the efficacy and safety of recombinant human interleukin-11 in the treatment of cancer therapy-induced… — Europe PMC PMID:42495717 — Europe PMC (en), https://europepmc.org/article/MED/42495717 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_477393bebf33 (Metraipolis archive dc_477393bebf33, sha256 bb0172d4af161b27a1d1a9cd1b6806960a95eed9f85cdd576a71abaec771369e)

BibTeX

@misc{dc477393bebf33,
  title = {Machine learning-based models for predicting the efficacy and safety of recombinant human interleukin-11 in the treatment of cancer therapy-induced… — Europe PMC PMID:42495717},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42495717},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_477393bebf33; sha256 bb0172d4af161b27a1d1a9cd1b6806960a95eed9f85cdd576a71abaec771369e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42495717. Agents can read the archived copy with the MCP tool read_document.